Literature DB >> 19050238

High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection.

Alleluiah Rutebemberwa1, Stuart C Ray, Jacquie Astemborski, Jordana Levine, Lin Liu, Kimberly A Dowd, Shalyn Clute, Changyu Wang, Alan Korman, Alessandro Sette, John Sidney, Drew M Pardoll, Andrea L Cox.   

Abstract

Hepatitis C virus (HCV) is an important human pathogen that represents a model for chronic infection given that the majority of infected individuals fail to clear the infection despite generation of virus-specific T cell responses during the period of acute infection. Although viral sequence evolution at targeted MHC class I-restricted epitopes represents one mechanism for immune escape in HCV, many targeted epitopes remain intact under circumstances of viral persistence. To explore alternative mechanisms of HCV immune evasion, we analyzed patterns of expression of a major inhibitory receptor on T cells, programmed death-1 (PD-1), from the time of initial infection and correlated these with HCV RNA levels, outcome of infection, and sequence escape within the targeted epitope. We show that the level of PD-1 expression in early HCV infection is significantly higher on HCV-specific T cells from subjects who progress to chronic HCV infection than from those who clear infection. This correlation is independent of HCV RNA levels, compatible with the notion that high PD-1 expression on HCV-specific CD8 T cells during acute infection inhibits viral clearance. Viral escape during persistent infection is associated with reduction in PD-1 levels on the surface of HCV-specific T cells, supporting the necessity of ongoing antigenic stimulation of T cells for maintenance of PD-1 expression. These results support the idea that PD-1 expression on T cells specific for nonescaped epitopes contributes to viral persistence and suggest that PD-1 blockade may alter the outcome of HCV infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19050238      PMCID: PMC2773824          DOI: 10.4049/jimmunol.181.12.8215

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion.

Authors:  H Dong; G Zhu; K Tamada; L Chen
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

2.  Estimating future hepatitis C morbidity, mortality, and costs in the United States.

Authors:  J B Wong; G M McQuillan; J G McHutchison; T Poynard
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

3.  PD-L2 is a second ligand for PD-1 and inhibits T cell activation.

Authors:  Y Latchman; C R Wood; T Chernova; D Chaudhary; M Borde; I Chernova; Y Iwai; A J Long; J A Brown; R Nunes; E A Greenfield; K Bourque; V A Boussiotis; L L Carter; B M Carreno; N Malenkovich; H Nishimura; T Okazaki; T Honjo; A H Sharpe; G J Freeman
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

4.  Hepatitis C virus mutation affects proteasomal epitope processing.

Authors:  Ulrike Seifert; Heike Liermann; Vito Racanelli; Anne Halenius; Manfred Wiese; Heiner Wedemeyer; Thomas Ruppert; Kay Rispeter; Peter Henklein; Alice Sijts; Hartmut Hengel; Peter-M Kloetzel; Barbara Rehermann
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

5.  Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.

Authors:  Todd M Allen; Marcus Altfeld; Xu G Yu; Kristin M O'Sullivan; Mathias Lichterfeld; Sylvie Le Gall; Mina John; Bianca R Mothe; Paul K Lee; Elizabeth T Kalife; Daniel E Cohen; Kenneth A Freedberg; Daryld A Strick; Mary N Johnston; Alessandro Sette; Eric S Rosenberg; Simon A Mallal; Philip J R Goulder; Christian Brander; Bruce D Walker
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

6.  Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.

Authors:  Yoshiyuki Yokomaku; Hideka Miura; Hiroko Tomiyama; Ai Kawana-Tachikawa; Masafumi Takiguchi; Asato Kojima; Yoshiyuki Nagai; Aikichi Iwamoto; Zene Matsuda; Koya Ariyoshi
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

7.  Variable patterns of programmed death-1 expression on fully functional memory T cells after spontaneous resolution of hepatitis C virus infection.

Authors:  David G Bowen; Naglaa H Shoukry; Arash Grakoui; Michael J Fuller; Andrew G Cawthon; Christine Dong; Dana L Hasselschwert; Kathleen M Brasky; Gordon J Freeman; Nilufer P Seth; Kai W Wucherpfennig; Michael Houghton; Christopher M Walker
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

8.  Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.

Authors:  G J Freeman; A J Long; Y Iwai; K Bourque; T Chernova; H Nishimura; L J Fitz; N Malenkovich; T Okazaki; M C Byrne; H F Horton; L Fouser; L Carter; V Ling; M R Bowman; B M Carreno; M Collins; C R Wood; T Honjo
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

9.  B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells.

Authors:  S Y Tseng; M Otsuji; K Gorski; X Huang; J E Slansky; S I Pai; A Shalabi; T Shin; D M Pardoll; H Tsuchiya
Journal:  J Exp Med       Date:  2001-04-02       Impact factor: 14.307

10.  Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection.

Authors:  Rika Draenert; Sylvie Le Gall; Katja J Pfafferott; Alasdair J Leslie; Polan Chetty; Christian Brander; Edward C Holmes; Shih-Chung Chang; Margaret E Feeney; Marylyn M Addo; Lidia Ruiz; Danni Ramduth; Prakash Jeena; Marcus Altfeld; Stephanie Thomas; Yanhua Tang; Cori L Verrill; Catherine Dixon; Julia G Prado; Photini Kiepiela; Javier Martinez-Picado; Bruce D Walker; Philip J R Goulder
Journal:  J Exp Med       Date:  2004-04-05       Impact factor: 14.307

View more
  67 in total

Review 1.  Decoding arenavirus pathogenesis: essential roles for alpha-dystroglycan-virus interactions and the immune response.

Authors:  Michael B A Oldstone; Kevin P Campbell
Journal:  Virology       Date:  2010-12-23       Impact factor: 3.616

2.  PD-1 negatively regulates interleukin-12 expression by limiting STAT-1 phosphorylation in monocytes/macrophages during chronic hepatitis C virus infection.

Authors:  Cheng J Ma; Lei Ni; Ying Zhang; C L Zhang; Xiao Y Wu; Antwan N Atia; Penny Thayer; Jonathan P Moorman; Zhi Q Yao
Journal:  Immunology       Date:  2010-11-23       Impact factor: 7.397

Review 3.  Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells.

Authors:  Barbara Rehermann
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

Review 4.  Adaptive immunity to the hepatitis C virus.

Authors:  Christopher M Walker
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

5.  Dynamic regulation of functionally distinct virus-specific T cells.

Authors:  Zaza M Ndhlovu; Mathias Oelke; Jonathan P Schneck; Diane E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-04       Impact factor: 11.205

6.  The frequency of CD127(+) hepatitis C virus (HCV)-specific T cells but not the expression of exhaustion markers predicts the outcome of acute HCV infection.

Authors:  Eui-Cheol Shin; Su-Hyung Park; Michelina Nascimbeni; Marian Major; Laura Caggiari; Valli de Re; Stephen M Feinstone; Charles M Rice; Barbara Rehermann
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

7.  Rare birds in North America: acute hepatitis C cohorts.

Authors:  Andrea L Cox; Kimberly Page; Julie Bruneau; Naglaa H Shoukry; Georg M Lauer; Arthur Y Kim; Hugo R Rosen; Hank Radziewicz; Arash Grakoui; Daniel S Fierer; Andrea D Branch; David E Kaplan; Kyong-Mi Chang
Journal:  Gastroenterology       Date:  2008-12-04       Impact factor: 22.682

8.  Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation.

Authors:  Bertram Bengsch; Bianca Seigel; Marianne Ruhl; Jörg Timm; Martin Kuntz; Hubert E Blum; Hanspeter Pircher; Robert Thimme
Journal:  PLoS Pathog       Date:  2010-06-10       Impact factor: 6.823

9.  T-cell dysfunction and inhibitory receptors in hepatitis C virus infection.

Authors:  Jino Lee; William I Suh; Eui-Cheol Shin
Journal:  Immune Netw       Date:  2010-08-31       Impact factor: 6.303

10.  Inhibitory TCR coreceptor PD-1 is a sensitive indicator of low-level replication of SIV and HIV-1.

Authors:  Nadine C Salisch; Daniel E Kaufmann; Amany S Awad; R Keith Reeves; Daniel P Tighe; Yuan Li; Michael Piatak; Jeffrey D Lifson; David T Evans; Florencia Pereyra; Gordon J Freeman; R Paul Johnson
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.